RxDoctor Payments Data

Carah Whichard, PA

Physician Assistant · Virginia Beach, VANPI 1366058232

Payments from drug & device makers

$2,339in general payments, 2019–2025

Across 65 payments — averaging $35.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$727
  • Bayer$293
  • Sumitomo Pharma America, Inc.$256
  • Myriad Genetic Laboratories, Inc.$186
  • Merck$165
  • Boston Scientific$135
  • plus $577 from 13 others

What the payments were for

  • Food & beverage$2,339100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,339 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$84,842
Medicare patients
518
Services billed
2,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OrgovyxRelugolix14$36,495
GemtesaVibegron18$12,772
MyrbetriqMirabegron17$11,194
Tamsulosin Hcl303$4,986
Finasteride122$1,244
Solifenacin Succinate12$954
Dutasteride30$863
Trospium Chloride15$685
Potassium Citrate ErPotassium Citrate13$638
Alfuzosin Hcl ErAlfuzosin Hcl15$459
Oxybutynin Chloride ErOxybutynin Chloride14$325
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$303
Ciprofloxacin Hcl49$226
Oxybutynin Chloride16$209
Vitamin D2Ergocalciferol (Vitamin D2)12$147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Orgovyx, Gemtesa$256$49,26732 claims
Astellas Pharma US IncMyrbetriq$33$11,19417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →